Gupta R - Search Results

1

HIV transmission dynamics and population-wide drug resistance in rural South Africa.

Gupta R, Kemp S, Kamelian K, Cuadros D, Gupta R, Cheng M, Okango E, Hanekom W, Ndung'u T, Pillay D, Bonsall D, Wong E, Tanser F, Siedner M. Gupta R, et al. Res Sq [Preprint]. 2023 Nov 28:rs.3.rs-3640717. doi: 10.21203/rs.3.rs-3640717/v1. Res Sq. 2023. PMID: 38076835 Free PMC article. Updated. Preprint.

2

HIV resistance and the developing world.

Gupta RK, Pillay D. Gupta RK, et al. Int J Antimicrob Agents. 2007 May;29(5):510-7. doi: 10.1016/j.ijantimicag.2007.01.003. Epub 2007 Mar 7. Int J Antimicrob Agents. 2007. PMID: 17346940 Review.

3

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.

Gupta R, Hill A, Sawyer AW, Pillay D. Gupta R, et al. Clin Infect Dis. 2008 Sep 1;47(5):712-22. doi: 10.1086/590943. Clin Infect Dis. 2008. PMID: 18662137

4

Management of paediatric HIV-1 resistance.

Gupta RK, Gibb DM, Pillay D. Gupta RK, et al. Curr Opin Infect Dis. 2009 Jun;22(3):256-63. doi: 10.1097/qco.0b013e3283298f1f. Curr Opin Infect Dis. 2009. PMID: 19405216 Free PMC article. Review.

5

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Gupta RK, Hill A, Sawyer AW, Cozzi-Lepri A, von Wyl V, Yerly S, Lima VD, Günthard HF, Gilks C, Pillay D. Gupta RK, et al. Lancet Infect Dis. 2009 Jul;9(7):409-17. doi: 10.1016/S1473-3099(09)70136-7. Lancet Infect Dis. 2009. PMID: 19555900

6

Causes and consequences of incomplete HIV RNA suppression in clinical trials.

Pozniak A, Gupta RK, Pillay D, Arribas J, Hill A. Pozniak A, et al. HIV Clin Trials. 2009 Sep-Oct;10(5):289-98. doi: 10.1310/hct1005-289. HIV Clin Trials. 2009. PMID: 19906623 Review.

7

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.

Gupta RK, Ford D, Mulenga V, Walker AS, Kabamba D, Kalumbi M, Grant PR, Ferrier A, Pillay D, Gibb DM, Chintu C. Gupta RK, et al. Pediatr Infect Dis J. 2010 Aug;29(8):e57-62. doi: 10.1097/INF.0b013e3181e47609. Pediatr Infect Dis J. 2010. PMID: 20508547

8

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays.

Gupta RK, Kohli A, McCormick AL, Towers GJ, Pillay D, Parry CM. Gupta RK, et al. AIDS. 2010 Jul 17;24(11):1651-5. doi: 10.1097/qad.0b013e3283398216. AIDS. 2010. PMID: 20597164 Free PMC article.

9

Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.

McCormick AL, Parry CM, Crombe A, Goodall RL, Gupta RK, Kaleebu P, Kityo C, Chirara M, Towers GJ, Pillay D. McCormick AL, et al. Antimicrob Agents Chemother. 2011 Apr;55(4):1806-9. doi: 10.1128/AAC.01197-10. Epub 2011 Jan 31. Antimicrob Agents Chemother. 2011. PMID: 21282419 Free PMC article.

10

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.

Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S. Gupta RK, et al. Lancet. 2012 Oct 6;380(9849):1250-8. doi: 10.1016/S0140-6736(12)61038-1. Epub 2012 Jul 23. Lancet. 2012. PMID: 22828485 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,374 results

Search Page